Every Form 4 that Genasys Inc. (GNSS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow GNSS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GNSS filings page.
Genasys Inc. (GNSS) director R. Rimmy Malhotra purchased 1,000 shares of common stock on 2026-08-26 in an open market or private transaction at $1.545 per share. Following this transaction, he directly owns 197,285 common shares, and he also has indirect ownership interests in additional shares held by Nicoya Fund, LLC and Nicoya Genasys-SPV LLC as described in the footnotes.
Genasys Inc. officer Cassandra L. Hernandez-Monteon, CFO/Treasurer/Secretary, reported a disposition to the issuer of 11,667 shares of common stock on May 14, 2026. This reflects the forfeiture of 11,667 restricted stock units that were subject to performance-based vesting because one of three fiscal 2026 performance measures was not achieved; the forfeiture was for no consideration. Following the transaction, she holds 76,039 shares of common stock directly and an additional 1,913 shares indirectly through her spouse, for which she disclaims beneficial ownership except to the extent of her pecuniary interest.
Danforth Richard reported disposition transactions in this Form 4 filing.
Genasys Inc. CEO and director Richard Danforth reported the forfeiture of 200,000 restricted stock units on May 14, 2026. These performance-based RSUs, granted on January 26, 2026 under the 2025 Equity Incentive Plan, were forfeited because the threshold performance measure for fiscal year 2026 was not achieved, and the forfeiture occurred for no consideration. Each RSU had represented a contingent right to receive one share of common stock. Following this forfeiture, Danforth directly holds 394,692 shares of Genasys common stock.
Genasys Inc. director Lawrence F. Hagenbuch received an equity grant of 48,498 restricted stock units (RSUs), each representing one share of Genasys common stock. The RSUs were granted as part of the company’s standard compensation for non-employee directors and carry no cash exercise price.
The RSUs vest on the earlier of the company’s 2027 annual shareholder meeting or a change of control. After this grant, Hagenbuch holds 48,498 shares or share-settled units directly, aligning his compensation further with shareholder equity performance.
Dodd William H reported acquisition or exercise transactions in this Form 4 filing.
Genasys Inc. director William H. Dodd received an equity award of 47,620 shares of common stock in the form of restricted stock units. The grant was a compensation-related award at no cash purchase price. Following this award, he holds 176,783 shares of common stock directly.
The RSUs vest upon the earlier of the company’s 2027 annual shareholder meeting or a change of control event. Each unit represents a contingent right to receive one share of Genasys common stock, settled solely in shares rather than cash.
Fugate William Craig reported acquisition or exercise transactions in this Form 4 filing.
Genasys Inc. director William Craig Fugate received a grant of 47,620 restricted stock units (RSUs) of common stock as equity compensation, with no cash purchase price. The RSUs vest upon the earlier of the company’s 2027 annual shareholder meeting or a change of control event. Each RSU represents a contingent right to one share of Genasys common stock, to be settled solely in shares. Following this award, Fugate directly holds 115,821 shares of the company’s common stock.
Malhotra R. Rimmy reported acquisition or exercise transactions in this Form 4 filing.
Genasys Inc. director R. Rimmy Malhotra reported receiving an award of 47,620 restricted stock units (RSUs) of common stock. These RSUs vest upon the earlier of the company’s 2027 annual shareholder meeting or a change of control, and each RSU represents one share settled solely in stock, with no cash purchase price.
After this grant, Malhotra holds 196,285 shares directly. The filing also lists indirect holdings of 1,628,495 Genasys shares owned by Nicoya Fund, LLC and 300 shares owned by Nicoya Genasys‑SPV LLC, entities managed through Nicoya Capital, LLC.
Genasys Inc. director Susan Lee Schmeiser reported receiving a grant of 47,620 shares of common stock in the form of restricted stock units at no cash cost. These RSUs vest upon the earlier of the company’s 2027 annual shareholder meeting or a change of control event. Each RSU converts into one share of common stock, deliverable only in shares. Following this grant, her reported direct holdings total 193,256 shares of Genasys common stock.
Genasys Inc. director William H. Dodd reported open-market purchases of a total of 25,457 shares of common stock. The transactions were completed on February 18 and 19, 2026 at prices between $1.97 and $1.98 per share. Following these purchases, he directly holds 129,163 shares.
Genasys Inc. CEO and director Richard Danforth received an equity grant of 400,000 shares of common stock on January 26, 2026 at a price of $0 per share. After this award, he beneficially owned 594,692 common shares, held directly.
The grant represents restricted stock units. According to the vesting terms, 50% of the units vest time‑based, with one‑third of that portion vesting on December 31, 2026 and the remaining two‑thirds on December 31, 2027. The other 50% will vest only if Genasys meets specified financial performance measures for fiscal year 2026.
Genasys Inc. interim CFO and Secretary Cassandra Monteon reported an equity grant of 10,000 shares of common stock in the form of restricted stock units on December 11, 2025 at a stated price of $0, indicating a compensation award rather than an open-market purchase.
The units vest in three equal installments: one-third on December 11, 2026, one-third on December 11, 2027, and one-third on December 11, 2028. After this grant, Monteon beneficially owns 17,706 shares directly and 1,913 shares indirectly through a spouse, with the indirect holdings disclaimed except for any pecuniary interest.